Human skin dendritic cells in health and disease

Journal of Dermatological Science

Volumn 77, Issue 2, 2015, Pages 85-92

  Haniffa, Muzlifah ^a,b   Gunawan, Merry ^a   Jardine, Laura ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antigen presenting cells; Dendritic cells; Mononuclear phagocytes; Skin

Indexed keywords

ARTICLE; ATOPIC DERMATITIS; DENDRITIC CELL; DISEASE MODEL; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; LYMPH NODE; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; SKIN; CLASSIFICATION; IMMUNOLOGY; INFLAMMATION; LANGERHANS CELL; MONONUCLEAR PHAGOCYTE; PATHOLOGY; PHYSIOLOGY;

BLOOD DENDRITIC CELL ANTIGEN 3, HUMAN; CD11 ANTIGEN; CD14 ANTIGEN; MEMBRANE ANTIGEN;

ANTIGENS, CD11; ANTIGENS, CD14; ANTIGENS, SURFACE; DERMATITIS, ATOPIC; HUMANS; INFLAMMATION; LANGERHANS CELLS; MONONUCLEAR PHAGOCYTE SYSTEM; PSORIASIS;

EID: 84927698372     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2014.08.012     Document Type: Review

References (94)

1. Stingl G., Wolff-Schreiner E.C., Pichler W.J., Gschnait F., Knapp W., Wolff K. Epidermal Langerhans cells bear Fc and C3 receptors. Nature 1977, 268:245-326.
2. Rowden G., Lewis M.G., Sullivan A.K. Ia antigen expression on human epidermal Langerhans cells. Nature 1977, 268:247-248.
3. Klareskog L., Tjernlund U., Forsum U., Peterson P.A. Epidermal Langerhans cells express Ia antigens. Nature 1977, 268:248-250.
4. Schuler G., Steinman R.M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 1985, 161:526-546.
5. Cerio R., Griffiths C.E., Cooper K.D., Nickoloff B.J., Headington J.T. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br. J. Dermatol. 1989, 121:421-431.
6. Lenz A., Heine M., Schuler G., Romani N. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J Clin Investig 1993, 92:2587-2596.
7. Nestle F.O., Zheng X.G., Thompson C.B., Turka L.A., Nickoloff B.J. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J. Immunol. 1993, 151:6535-6545.
8. Zaba L.C., Fuentes-Duculan J., Steinman R.M., Krueger J.G., Lowes M.A. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J Clin Investig 2007, 117:2517-2525.
9. Haniffa M., Ginhoux F., Wang X.N., Bigley V., Abel M., Dimmick I., et al. Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation. J. Exp. Med. 2009, 206:371-385.
10. Haniffa M., Shin A., Bigley V., McGovern N., Teo P., See P., et al. Human tissues contain CD141(hi) cross-presenting dendritic cells with functional homology to mouse CD103(+) nonlymphoid dendritic cells. Immunity 2012, 37:60-73.
11. + dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. J Exp Med 2012, 209:935-945.
12. Wang X.N., McGovern N., Gunawan M., Richardson C., Windebank M., Siah T.W., et al. A three-dimensional atlas of human dermal leukocytes, lymphatics, and blood vessels. J Investig Dermatol 2014, 134:965-974.
13. Haniffa M., Collin M., Ginhoux F. Ontogeny and functional specialization of dendritic cells in human and mouse. Adv. Immunol. 2013, 120:1-49.
14. McGovern N., Schlitzer A., Gunawan M., Jardine L., Shin A., Poyner E., et al. Human Dermal CD14(+) Cells are a Transient Population of Monocyte-Derived Macrophages. Immunity 2004, 41(3):465-477.
15. Nestle F.O., Conrad C., Tun-Kyi A., Homey B., Gombert M., Boyman O., et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J.Exp.Med 2005, 202:135-143.
16. Albanesi C., Scarponi C., Pallotta S., Daniele R., Bosisio D., Madonna S., et al. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med. 2009, 206:249-258.
17. Grouard G., Rissoan M.C., Filgueira L., Durand I., Banchereau J., Liu Y.J. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 1997, 185:1101-1111.
18. Cox K., North M., Burke M., Singhal H., Renton S., Aqel N., et al. Plasmacytoid dendritic cells (PDC) are the major DC subset innately producing cytokines in human lymph nodes. J. Leukoc. Biol. 2005, 78:1142-1152.
19. Caux C., Vanbervliet B., Massacrier C., Dezutter-Dambuyant C., de Saint-Vis B., Jacquet C., et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+ TNF alpha. J. Exp. Med. 1996, 184:695-706.
20. Klechevsky E., Morita R., Liu M., Cao Y., Coquery S., Thompson-Snipes L., et al. Functional specializations of human epidermal langerhans cells and CD14+ dermal dendritic cells. Immunity 2008, 29:497-510.
21. Morelli A.E., Rubin J.P., Erdos G., Tkacheva O.A., Mathers A.R., Zahorchak A.F., et al. Larregina AT: CD4+ T cell responses elicited by different subsets of human skin migratory dendritic cells. J. Immunol. 2005, 175:7905-7915.
22. de Gruijl T.D., Sombroek C.C., Lougheed S.M., Oosterhoff D., Buter J., van den Eertwegh A.J., et al. A postmigrational switch among skin-derived dendritic cells to a macrophage-like phenotype is predetermined by the intracutaneous cytokine balance. J. Immunol. 2006, 176:7232-7242.
23. Angel C.E., George E., Brooks A.E., Ostrovsky L.L., Brown T.L., Dunbar P.R. Cutting edge: CD1a+ antigen-presenting cells in human dermis respond rapidly to CCR7 ligands. J. Immunol. 2006, 176:5730-5734.
24. Polak M.E., Newell L., Taraban V.Y., Pickard C., Healy E., Friedmann P.S., et al. CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells. J Investig Dermatol 2012, 132:1636-1644.
25. Lindenberg J.J., Oosterhoff D., Sombroek C.C., Lougheed S.M., Hooijberg E., Stam A.G., et al. IL-10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiation. PLoS One 2013, 8:e70237.
26. Larregina A.T., Morelli A.E., Spencer L.A., Logar A.J., Watkins S.C., Thomson A.W., et al. Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat. Immunol. 2001, 2:1151-1158.
27. Maraskovsky E., Daro E., Roux E., Teepe M., Maliszewski C.R., Hoek J., et al. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 2000, 96:878-884.
28. McKenna H.J., Stocking K.L., Miller R.E., Brasel K., De Smedt T., Maraskovsky E., et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000, 95:3489-3497.
29. Chen W., Chan A.S., Dawson A.J., Liang X., Blazar B.R., Miller J.S. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function. Biol. Blood Marrow Transplant. 2005, 11:23-34.
30. Hambleton S., Salem S., Bustamante J., Bigley V., Boisson-Dupuis S., Azevedo J., et al. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 2011.
31. Bigley V., Haniffa M., Doulatov S., Wang X.N., Dickinson R., McGovern N., et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J. Exp. Med. 2011, 208:227-234.
32. Hoeffel G., Wang Y., Greter M., See P., Teo P., Malleret B., et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J. Exp. Med. 2012, 209:1167-1181.
33. Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336:86-90.
34. Merad M., Manz M.G., Karsunky H., Wagers A., Peters W., Charo I., et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 2002, 3:1135-1141.
35. Chorro L., Sarde A., Li M., Woollard K.J., Chambon P., Malissen B., et al. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J. Exp. Med. 2009, 206:3089-3100.
36. Van Voorhis W.C., Hair L.S., Steinman R.M., Kaplan G. Human dendritic cells. Enrichment and characterization from peripheral blood. J. Exp. Med. 1982, 155:1172-1187.
37. O'Doherty U., Peng M., Gezelter S., Swiggard W.J., Betjes M., Bhardwaj N., et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994, 82:487-493.
38. MacDonald K.P., Munster D.J., Clark G.J., Dzionek A., Schmitz J., Hart D.N. Characterization of human blood dendritic cell subsets. Blood 2002, 100:4512-4520.
39. Schakel K., von Kietzell M., Hansel A., Ebling A., Schulze L., Haase M., et al. Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes. Immunity 2006, 24:767-777.
40. Gunther C., Starke J., Zimmermann N., Schakel K. Human 6-sulfo LacNAc (slan) dendritic cells are a major population of dermal dendritic cells in steady state and inflammation. Clin. Exp. Dermatol. 2012, 37:169-176.
41. Robbins S.H., Walzer T., Dembele D., Thibault C., Defays A., Bessou G., et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 2008, 9:R17.
42. Bachem A., Guttler S., Hartung E., Ebstein F., Schaefer M., Tannert A., et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J. Exp. Med. 2010, 207:1273-1281.
43. Crozat K., Guiton R., Contreras V., Feuillet V., Dutertre C.A., Ventre E., et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J. Exp. Med. 2010, 207:1283-1292.
44. Jongbloed S.L., Kassianos A.J., McDonald K.J., Clark G.J., Ju X., Angel C.E., et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 2010, 207:1247-1260.
45. Poulin L.F., Salio M., Griessinger E., Anjos-Afonso F., Craciun L., Chen J.L., et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J. Exp. Med. 2010, 207:1261-1271.
46. Schlitzer A., McGovern N., Teo P., Zelante T., Atarashi K., Low D., et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 2013, 38:970-983.
47. Serbina N.V., Salazar-Mather T.P., Biron C.A., Kuziel W.A., Pamer E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59-70.
48. Leon B., Lopez-Bravo M., Ardavin C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 2007, 26:519-531.
49. Segura E., Touzot M., Bohineust A., Cappuccio A., Chiocchia G., Hosmalin A., et al. Human inflammatory dendritic cells induce th17 cell differentiation. Immunity 2013, 38:336-348.
50. Lowes M.A., Chamian F., Abello M.V., Fuentes-Duculan J., Lin S.L., Nussbaum R., et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl. Acad. Sci. U. S. A. 2005, 102:19057-19062.
51. Wollenberg A., Mommaas M., Oppel T., Schottdorf E.M., Gunther S., Moderer M. Expression and function of the mannose receptor CD206 on epidermal dendritic cells in inflammatory skin diseases. J Investig Dermatol 2002, 118:327-334.
52. Nestle F.O., Conrad C., Tun-Kyi A., Homey B., Gombert M., Boyman O., et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J. Exp. Med. 2005, 202:135-143.
53. Hansel A., Gunther C., Ingwersen J., Starke J., Schmitz M., Bachmann M., et al. Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses. J. Allergy Clin. Immunol. 2011, 127:787-794. e1-9.
54. Wollenberg A., Wagner M., Gunther S., Towarowski A., Tuma E., Moderer M., et al. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J Investig Dermatol 2002, 119:1096-1102.
55. Bieber T., Kraft S., Geiger E., Wollenberg A., Koch S., Novak N. Fc [correction of Ec] epsilon RI expressing dendritic cells: the missing link in the pathophysiology of atopic dermatitis?. J. Dermatol. 2000, 27:698-699.
56. Stary G., Bangert C., Stingl G., Kopp T. Dendritic cells in atopic dermatitis: expression of FcepsilonRI on two distinct inflammation-associated subsets. Int. Arch. Allergy Immunol. 2005, 138:278-290.
57. Wollenberg A., Kraft S., Hanau D., Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Investig Dermatol 1996, 106:446-453.
58. Cheong C., Matos I., Choi J.H., Dandamudi D.B., Shrestha E., Longhi M.P., et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 2010, 143:416-429.
59. Plantinga M., Guilliams M., Vanheerswynghels M., Deswarte K., Branco-Madeira F., Toussaint W., et al. Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity 2013, 38:322-335.
60. Tamoutounour S., Guilliams M., Montanana Sanchis F., Liu H., Terhorst D., Malosse C., et al. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 2013, 39:925-938.
61. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80.
62. Serbina N.V., Kuziel W., Flavell R., Akira S., Rollins B., Pamer E.G. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity 2003, 19:891-901.
63. Greter M., Helft J., Chow A., Hashimoto D., Mortha A., Agudo-Cantero J., et al. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity 2012, 36:1031-1046.
64. Manh T.P., Alexandre Y., Baranek T., Crozat K., Dalod M. Plasmacytoid, conventional, and monocyte-derived dendritic cells undergo a profound and convergent genetic reprogramming during their maturation. Eur. J. Immunol. 2013, 43:1706-1715.
65. Novak N., Kraft S., Haberstok J., Geiger E., Allam P., Bieber T. A reducing microenvironment leads to the generation of FcepsilonRIhigh inflammatory dendritic epidermal cells (IDEC). J. Invest. Dermatol. 2002, 119:842-849.
66. Ginhoux F., Tacke F., Angeli V., Bogunovic M., Loubeau M., Dai X.M., et al. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 2006, 7:265-273.
67. Sere K., Baek J.H., Ober-Blobaum J., Muller-Newen G., Tacke F., Yokota Y., et al. Two distinct types of Langerhans cells populate the skin during steady state and inflammation. Immunity 2012, 37:905-916.
68. Collin M.P., Hart D.N., Jackson G.H., Cook G., Cavet J., Mackinnon S., et al. The fate of human Langerhans cells in hematopoietic stem cell transplantation. J. Exp. Med. 2006, 203:27-33.
69. Serbina N.V., Hohl T.M., Cherny M., Pamer E.G. Selective expansion of the monocytic lineage directed by bacterial infection. J. Immunol. 2009, 183:1900-1910.
70. Ballesteros-Tato A., Leon B., Lund F.E., Randall T.D. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat. Immunol. 2010, 11:216-224.
71. Kool M., Soullie T., van Nimwegen M., Willart M.A., Muskens F., Jung S., et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 2008, 205:869-882.
72. Wakim L.M., Waithman J., van Rooijen N., Heath W.R., Carbone F.R. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 2008, 319:198-202.
73. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007, 8:639-646.
74. Nair R.P., Duffin K.C., Helms C., Ding J., Stuart P.E., Goldgar D., et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat. Genet. 2009, 41:199-204.
75. Zaba L.C., Cardinale I., Gilleaudeau P., Sullivan-Whalen M., Suarez Farinas M., Fuentes-Duculan J., et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 2007, 204:3183-3194.
76. Lee E., Trepicchio W.L., Oestreicher J.L., Pittman D., Wang F., Chamian F., et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 2004, 199:125-130.
77. Cragg M.S., Walshe C.A., Ivanov A.O., Glennie M.J. The biology of CD20 and its potential as a target for mAb therapy. Curr. Dir. Autoimmun. 2005, 8:140-174.
78. Fujita H., Shemer A., Suarez-Farinas M., Johnson-Huang L.M., Tintle S., Cardinale I., et al. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets. J. Allergy Clin. Immunol. 2011, 128:574-582. (e1-12).
79. Boyman O., Hefti H.P., Conrad C., Nickoloff B.J., Suter M., Nestle F.O. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J. Exp. Med. 2004, 199:731-736.
80. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 2006, 38:441-446.
81. Kabashima K. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J. Dermatol. Sci. 2013, 70:3-11.
82. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 2002, 3:673-680.
83. Nograles K.E., Zaba L.C., Shemer A., Fuentes-Duculan J., Cardinale I., Kikuchi T., et al. IL-22-producing T22 T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J. Allergy Clin. Immunol. 2009, 123:1244-1252. e2.
84. Duhen T., Geiger R., Jarrossay D., Lanzavecchia A., Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 2009, 10:857-863.
85. Novak N., Allam J.P., Hagemann T., Jenneck C., Laffer S., Valenta R., et al. Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J. Allergy Clin. Immunol. 2004, 114:364-370.
86. Romani N., Brunner P.M., Stingl G. Changing views of the role of Langerhans cells. J Investig Dermatol 2012, 132(3 Pt 2):872-881.
87. Penel-Sotirakis K., Simonazzi E., Péguet-Navarro J., Rozières A. Differential capacity of human skin dendritic cells to polarize CD4+ T cells into IL-17, IL-21 and IL-22 producing cells. PLoS One 2012, 7(11):e45680.
88. Matthews K., Chung N.P., Klasse P.J., Romani N., Brunner P.M., Stingl G. Changing views of the role of Langerhans cells. J Investig Dermatol 2012, 132(3 Pt 2):872-881.
89. Igyarto B.Z., Haley K., Ortner D., Bobr A., Gerami-Nejad M., Edelson B.T., et al. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 2011, 35:260-272.
90. Sancho D., Joffre O.P., Keller A.M., Rogers N.C., Martinez D., Hernanz-Falcon P., et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009, 458(7240):899-903.
91. Dudziak D., Kamphorst A.O., Heidkamp G.F., Buchholz V.R., Trumpfheller C., Yamazaki S., et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007, 315(5808):107-111.
92. del Rio M.L., Bernhardt G., Rodriguez-Barbosa J.I., Forster R. Development and functional specialization of CD103 dendritic cells. Immunol. Rev. 2010, 234(1):268-281.
93. den Haan J.M., Bevan M.J. Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J Exp Med 2002, 196(6):817-827.
94. Edelson B.T., KC W., Juang R., Kohyama M., Benoit L.A., Klekotka P.A., et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J Exp Med 2010, 207(4):823-836.